Bristol Myers Squibb, Repertoire Enters $1.8 Billion Deal to Develop Vaccines for Autoimmune Diseases

The multi-year collaboration aims to develop tolerizing vaccines for up to 3 autoimmune diseases.

Related Keywords

Bristol Myers Squibb ,Francisco Ram ,Immunology Cardiovascular Thematic Research Center ,Repertoire Immune Medicines ,Myers Squibb ,Cardiovascular Thematic Research Center ,Torben Straight Nissen ,Flagship Pioneering ,Tolerizing Vaccines ,Autoimmune Disease Vaccines ,Autoimmune Diseases ,